trial
as of 2026-07-01Tolerance and Effect of Antipsychotics in Children and Adolescents With Psychosis
NCTId NCT01119014
at a glance
Phase 4 · Completed
Enrollment 300 (actual)
Sponsored by Anne Katrine Pagsberg
Primary completion 2015-07
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Completed
Enrollment
300 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2010-05
Primary completion
2015-07
Eligibility
ALL · 12 Years · 17 Years
Interventions & indications
Indications
Sponsors
Anne Katrine PagsbergLead Sponsor
Psychiatric Centre Copenhagen, DenmarkCollaborator
Albert Einstein College of MedicineCollaborator
Region Capital DenmarkCollaborator
AP Moeller FoundationCollaborator
Tryg Fonden, DenmarkCollaborator
Investigators
9
Anne Katrine Pagsberg, MD, Ph.D.Principal Investigator
Pia Jeppesen, MD, Ph.D.Principal Investigator
Maj-Britt Lauritsen, MDPrincipal Investigator
Per Hove-Thomsen, Professor, MD, D.M.Sci.Principal Investigator
Marlene Briciet Lauritsen, MD.Principal Investigator
Niels Bilenberg, Professor, MD.Principal Investigator
Thomas Werge, Professor, Ph.D.Principal Investigator
Anders Fink-Jensen, MD, professor, DMSci.Principal Investigator
Jesper Pedersen, MD.Principal Investigator
Sites
9 total
Aalborg, DenmarkCopenhagen, DenmarkCopenhagen, DenmarkGlostrup Municipality, DenmarkHillerød, DenmarkOdense, DenmarkRisskov, DenmarkRoskilde, DenmarkRoskilde, Denmark
Facts & assertions
4 sourced
Enrollment
300
Phase
PHASE4
Primary Completion Date
2015-07
Status
COMPLETED
relationships
The graph out of here
drug
drug
drug
lead_sponsor
company
collaborator
indication
indication
indication
investigator